Pediatric Global Health in Children with Very Early-Onset Inflammatory Bowel Disease

Christina E Holbein1, Jill Plevinsky1,2, Trusha Patel3,4

  • 1Department of Child & Adolescent Psychiatry and Behavioral Sciences, The Children's Hospital of Philadelphia.

Insights

Children with very early-onset inflammatory bowel disease (VEO-IBD) experience lower quality of life, with gastrointestinal symptoms explaining the difference. Many VEO-IBD children show resilience, but psychosocial screening is vital for support.

Area of Science:

  • Pediatric gastroenterology
  • Child psychology
  • Health-related quality of life research

Background:

  • Very early-onset inflammatory bowel disease (VEO-IBD) is distinct but often excluded from psychosocial studies.
  • Understanding health-related quality of life (HRQOL) in VEO-IBD is crucial for comprehensive care.

Purpose of the Study:

  • Assess HRQOL in children with VEO-IBD using a novel pediatric global health measure.
  • Compare HRQOL between children with VEO-IBD and healthy peers.
  • Determine if gastrointestinal symptoms mediate differences in HRQOL.

Main Methods:

  • Caregivers of 51 children with VEO-IBD and 54 healthy children completed the PROMIS Pediatric Global Health Scale (PGH-7).
  • Gastrointestinal symptom questionnaires were administered.
  • Statistical analyses included ANCOVA and bootstrapping mediation analyses.

Main Results:

  • Caregivers reported generally positive HRQOL for children with VEO-IBD, but lower scores on specific items with increased disease severity.
  • Children with VEO-IBD scored significantly lower on overall health, physical health, mental health, and quality of life compared to healthy children.
  • Gastrointestinal symptoms significantly mediated the relationship between health status and HRQOL.

Conclusions:

  • While many children with VEO-IBD demonstrate resilience, some are at risk for HRQOL deficits.
  • Psychosocial screening is essential for identifying needs and facilitating referrals to behavioral health services.
  • Further research on psychosocial adjustment in VEO-IBD is warranted.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
477
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
465
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
246
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
444
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
264
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
576